Novel protein kinase C, nPKC, inhibition of murine bumetanide-sensitive Na+,K+,2Cl- cotransporter BSC1 in Xenopus oocyte
In vitro transcribed RNAs obtained for the absorptive type of Na,K, 2Cl cotransporter BSC1, isoform F, and either of three deletion mutants were injected into oocytes, while oocytes injected with water served as controls. Wild-type cRNA induced a bumetanide-sensitive Rb flux after 18 h which rose to...
Gespeichert in:
Veröffentlicht in: | Pflügers Archiv 1998-07, Vol.436 (2), p.189-198 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 198 |
---|---|
container_issue | 2 |
container_start_page | 189 |
container_title | Pflügers Archiv |
container_volume | 436 |
creator | Baekgaard, A Bindslev, N |
description | In vitro transcribed RNAs obtained for the absorptive type of Na,K, 2Cl cotransporter BSC1, isoform F, and either of three deletion mutants were injected into oocytes, while oocytes injected with water served as controls. Wild-type cRNA induced a bumetanide-sensitive Rb flux after 18 h which rose to a maximum of about 600 pmol . (h.oocyte)-1 during the next 24 h. This level of flux lasted for at least 31/2 days. All deletion mutants were either not expressed and/or were non-functional. The protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) eliminated the induced flux, with an apparent dissociation constant (aKi) of 6 nM. A 15 nM PMA-elicited inhibition of Rb flux was blocked by the PKC inhibitor calphostin C (200 nM) to approximately 80%, while PKC inhibitors staurosporine (40 nM) and Gö6976 (50 nM) were ineffective. The phosphatase inhibitor okadaic acid (4.6 nM) did not influence PMA-induced flux inhibition. The PKC activator sn-1, 2-dioctanoyl glycerol (DOG), even at 2 microM, did not inhibit bumetanide-sensitive Rb influx. The induced Rb fluxes were not affected by PKA or PKG, as stimulation by either 0.5 mM dibutyryl-cAMP, 0.5 mM dibutyryl-cGMP, 10 microM forskolin, and/or 0. 5 mM theophylline had no effect on bumetanide-sensitive Rb fluxes. Activating endogenous muscarinic receptors with 20 microM acetylcholine had no effect on expressed BSC1 fluxes. The sensitivity to bumetanide of induced Rb flux had an aKi of around 70 nM. Attempts to follow the expression of BSC1 in plasma membranes with either immunoblotting or radio-methionine pulse-chase were unsuccessful. We conclude that a PKC, likely of the novel type, nPKC, seems to be involved in PMA-induced reduction of expressed BSC1 and/or its ion transport function. |
doi_str_mv | 10.1007/s004240050622 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_874022783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2386652191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-72269c6fc782faa4c13f7f8bf9560e85975e8c46f1dd6e8eaa89e24137431ee73</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMotVaPHoXgtV2dfOwme9TFLxQVVPC2pNsJRtukJrvF_ntXLIKXeQ_z8A7zEHLI4IQBqNMEILkEyKHgfIsMmRQ848DENhkCCJYVqtC7ZC-ldwDgUvMBGZR5KYHpIfm6Dyuc02UMLTpPP5w3CWk1of7xtp_Ov7mpa13wNFi66KLzSKfdAlvj3QyzhD716xXSezOe3I4nvJpntAltND4tQ2wx0vOnivVF9BV9WHaJhtCsW9wnO9bMEx5sckReLi-eq-vs7uHqpjq7yxrB8jZTnBdlU9hGaW6NkQ0TVlk9tWVeAOq8VDnqRhaWzWYFajRGl8glE0oKhqjEiBz_9vYvfnaY2vo9dNH3J2utJHCutOih7BdqYkgpoq2X0S1MXNcM6h_L9T_LPX-0Ke2mC5z90Rut4hs5RnY4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>874022783</pqid></control><display><type>article</type><title>Novel protein kinase C, nPKC, inhibition of murine bumetanide-sensitive Na+,K+,2Cl- cotransporter BSC1 in Xenopus oocyte</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Baekgaard, A ; Bindslev, N</creator><creatorcontrib>Baekgaard, A ; Bindslev, N</creatorcontrib><description>In vitro transcribed RNAs obtained for the absorptive type of Na,K, 2Cl cotransporter BSC1, isoform F, and either of three deletion mutants were injected into oocytes, while oocytes injected with water served as controls. Wild-type cRNA induced a bumetanide-sensitive Rb flux after 18 h which rose to a maximum of about 600 pmol . (h.oocyte)-1 during the next 24 h. This level of flux lasted for at least 31/2 days. All deletion mutants were either not expressed and/or were non-functional. The protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) eliminated the induced flux, with an apparent dissociation constant (aKi) of 6 nM. A 15 nM PMA-elicited inhibition of Rb flux was blocked by the PKC inhibitor calphostin C (200 nM) to approximately 80%, while PKC inhibitors staurosporine (40 nM) and Gö6976 (50 nM) were ineffective. The phosphatase inhibitor okadaic acid (4.6 nM) did not influence PMA-induced flux inhibition. The PKC activator sn-1, 2-dioctanoyl glycerol (DOG), even at 2 microM, did not inhibit bumetanide-sensitive Rb influx. The induced Rb fluxes were not affected by PKA or PKG, as stimulation by either 0.5 mM dibutyryl-cAMP, 0.5 mM dibutyryl-cGMP, 10 microM forskolin, and/or 0. 5 mM theophylline had no effect on bumetanide-sensitive Rb fluxes. Activating endogenous muscarinic receptors with 20 microM acetylcholine had no effect on expressed BSC1 fluxes. The sensitivity to bumetanide of induced Rb flux had an aKi of around 70 nM. Attempts to follow the expression of BSC1 in plasma membranes with either immunoblotting or radio-methionine pulse-chase were unsuccessful. We conclude that a PKC, likely of the novel type, nPKC, seems to be involved in PMA-induced reduction of expressed BSC1 and/or its ion transport function.</description><identifier>ISSN: 0031-6768</identifier><identifier>EISSN: 1432-2013</identifier><identifier>DOI: 10.1007/s004240050622</identifier><identifier>PMID: 9594018</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Animals ; Bumetanide - pharmacology ; Carrier Proteins - antagonists & inhibitors ; Carrier Proteins - genetics ; Carrier Proteins - physiology ; Enzyme Activation - drug effects ; Enzyme Inhibitors - pharmacology ; Female ; Gene Transfer Techniques ; Kinases ; Mice ; Naphthalenes - pharmacology ; Oocytes - metabolism ; Protein Kinase C - antagonists & inhibitors ; Protein Kinase C - metabolism ; Proteins ; Recombinant Proteins ; Rubidium - metabolism ; Sodium-Potassium-Chloride Symporters ; Staurosporine - pharmacology ; Tetradecanoylphorbol Acetate - pharmacology ; Xenopus</subject><ispartof>Pflügers Archiv, 1998-07, Vol.436 (2), p.189-198</ispartof><rights>Springer-Verlag Berlin Heidelberg 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-72269c6fc782faa4c13f7f8bf9560e85975e8c46f1dd6e8eaa89e24137431ee73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9594018$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baekgaard, A</creatorcontrib><creatorcontrib>Bindslev, N</creatorcontrib><title>Novel protein kinase C, nPKC, inhibition of murine bumetanide-sensitive Na+,K+,2Cl- cotransporter BSC1 in Xenopus oocyte</title><title>Pflügers Archiv</title><addtitle>Pflugers Arch</addtitle><description>In vitro transcribed RNAs obtained for the absorptive type of Na,K, 2Cl cotransporter BSC1, isoform F, and either of three deletion mutants were injected into oocytes, while oocytes injected with water served as controls. Wild-type cRNA induced a bumetanide-sensitive Rb flux after 18 h which rose to a maximum of about 600 pmol . (h.oocyte)-1 during the next 24 h. This level of flux lasted for at least 31/2 days. All deletion mutants were either not expressed and/or were non-functional. The protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) eliminated the induced flux, with an apparent dissociation constant (aKi) of 6 nM. A 15 nM PMA-elicited inhibition of Rb flux was blocked by the PKC inhibitor calphostin C (200 nM) to approximately 80%, while PKC inhibitors staurosporine (40 nM) and Gö6976 (50 nM) were ineffective. The phosphatase inhibitor okadaic acid (4.6 nM) did not influence PMA-induced flux inhibition. The PKC activator sn-1, 2-dioctanoyl glycerol (DOG), even at 2 microM, did not inhibit bumetanide-sensitive Rb influx. The induced Rb fluxes were not affected by PKA or PKG, as stimulation by either 0.5 mM dibutyryl-cAMP, 0.5 mM dibutyryl-cGMP, 10 microM forskolin, and/or 0. 5 mM theophylline had no effect on bumetanide-sensitive Rb fluxes. Activating endogenous muscarinic receptors with 20 microM acetylcholine had no effect on expressed BSC1 fluxes. The sensitivity to bumetanide of induced Rb flux had an aKi of around 70 nM. Attempts to follow the expression of BSC1 in plasma membranes with either immunoblotting or radio-methionine pulse-chase were unsuccessful. We conclude that a PKC, likely of the novel type, nPKC, seems to be involved in PMA-induced reduction of expressed BSC1 and/or its ion transport function.</description><subject>Animals</subject><subject>Bumetanide - pharmacology</subject><subject>Carrier Proteins - antagonists & inhibitors</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - physiology</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Female</subject><subject>Gene Transfer Techniques</subject><subject>Kinases</subject><subject>Mice</subject><subject>Naphthalenes - pharmacology</subject><subject>Oocytes - metabolism</subject><subject>Protein Kinase C - antagonists & inhibitors</subject><subject>Protein Kinase C - metabolism</subject><subject>Proteins</subject><subject>Recombinant Proteins</subject><subject>Rubidium - metabolism</subject><subject>Sodium-Potassium-Chloride Symporters</subject><subject>Staurosporine - pharmacology</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Xenopus</subject><issn>0031-6768</issn><issn>1432-2013</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpVkE1LAzEQhoMotVaPHoXgtV2dfOwme9TFLxQVVPC2pNsJRtukJrvF_ntXLIKXeQ_z8A7zEHLI4IQBqNMEILkEyKHgfIsMmRQ848DENhkCCJYVqtC7ZC-ldwDgUvMBGZR5KYHpIfm6Dyuc02UMLTpPP5w3CWk1of7xtp_Ov7mpa13wNFi66KLzSKfdAlvj3QyzhD716xXSezOe3I4nvJpntAltND4tQ2wx0vOnivVF9BV9WHaJhtCsW9wnO9bMEx5sckReLi-eq-vs7uHqpjq7yxrB8jZTnBdlU9hGaW6NkQ0TVlk9tWVeAOq8VDnqRhaWzWYFajRGl8glE0oKhqjEiBz_9vYvfnaY2vo9dNH3J2utJHCutOih7BdqYkgpoq2X0S1MXNcM6h_L9T_LPX-0Ke2mC5z90Rut4hs5RnY4</recordid><startdate>19980701</startdate><enddate>19980701</enddate><creator>Baekgaard, A</creator><creator>Bindslev, N</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>19980701</creationdate><title>Novel protein kinase C, nPKC, inhibition of murine bumetanide-sensitive Na+,K+,2Cl- cotransporter BSC1 in Xenopus oocyte</title><author>Baekgaard, A ; Bindslev, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-72269c6fc782faa4c13f7f8bf9560e85975e8c46f1dd6e8eaa89e24137431ee73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Animals</topic><topic>Bumetanide - pharmacology</topic><topic>Carrier Proteins - antagonists & inhibitors</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - physiology</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Female</topic><topic>Gene Transfer Techniques</topic><topic>Kinases</topic><topic>Mice</topic><topic>Naphthalenes - pharmacology</topic><topic>Oocytes - metabolism</topic><topic>Protein Kinase C - antagonists & inhibitors</topic><topic>Protein Kinase C - metabolism</topic><topic>Proteins</topic><topic>Recombinant Proteins</topic><topic>Rubidium - metabolism</topic><topic>Sodium-Potassium-Chloride Symporters</topic><topic>Staurosporine - pharmacology</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Xenopus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baekgaard, A</creatorcontrib><creatorcontrib>Bindslev, N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Pflügers Archiv</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baekgaard, A</au><au>Bindslev, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel protein kinase C, nPKC, inhibition of murine bumetanide-sensitive Na+,K+,2Cl- cotransporter BSC1 in Xenopus oocyte</atitle><jtitle>Pflügers Archiv</jtitle><addtitle>Pflugers Arch</addtitle><date>1998-07-01</date><risdate>1998</risdate><volume>436</volume><issue>2</issue><spage>189</spage><epage>198</epage><pages>189-198</pages><issn>0031-6768</issn><eissn>1432-2013</eissn><abstract>In vitro transcribed RNAs obtained for the absorptive type of Na,K, 2Cl cotransporter BSC1, isoform F, and either of three deletion mutants were injected into oocytes, while oocytes injected with water served as controls. Wild-type cRNA induced a bumetanide-sensitive Rb flux after 18 h which rose to a maximum of about 600 pmol . (h.oocyte)-1 during the next 24 h. This level of flux lasted for at least 31/2 days. All deletion mutants were either not expressed and/or were non-functional. The protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) eliminated the induced flux, with an apparent dissociation constant (aKi) of 6 nM. A 15 nM PMA-elicited inhibition of Rb flux was blocked by the PKC inhibitor calphostin C (200 nM) to approximately 80%, while PKC inhibitors staurosporine (40 nM) and Gö6976 (50 nM) were ineffective. The phosphatase inhibitor okadaic acid (4.6 nM) did not influence PMA-induced flux inhibition. The PKC activator sn-1, 2-dioctanoyl glycerol (DOG), even at 2 microM, did not inhibit bumetanide-sensitive Rb influx. The induced Rb fluxes were not affected by PKA or PKG, as stimulation by either 0.5 mM dibutyryl-cAMP, 0.5 mM dibutyryl-cGMP, 10 microM forskolin, and/or 0. 5 mM theophylline had no effect on bumetanide-sensitive Rb fluxes. Activating endogenous muscarinic receptors with 20 microM acetylcholine had no effect on expressed BSC1 fluxes. The sensitivity to bumetanide of induced Rb flux had an aKi of around 70 nM. Attempts to follow the expression of BSC1 in plasma membranes with either immunoblotting or radio-methionine pulse-chase were unsuccessful. We conclude that a PKC, likely of the novel type, nPKC, seems to be involved in PMA-induced reduction of expressed BSC1 and/or its ion transport function.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>9594018</pmid><doi>10.1007/s004240050622</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0031-6768 |
ispartof | Pflügers Archiv, 1998-07, Vol.436 (2), p.189-198 |
issn | 0031-6768 1432-2013 |
language | eng |
recordid | cdi_proquest_journals_874022783 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Bumetanide - pharmacology Carrier Proteins - antagonists & inhibitors Carrier Proteins - genetics Carrier Proteins - physiology Enzyme Activation - drug effects Enzyme Inhibitors - pharmacology Female Gene Transfer Techniques Kinases Mice Naphthalenes - pharmacology Oocytes - metabolism Protein Kinase C - antagonists & inhibitors Protein Kinase C - metabolism Proteins Recombinant Proteins Rubidium - metabolism Sodium-Potassium-Chloride Symporters Staurosporine - pharmacology Tetradecanoylphorbol Acetate - pharmacology Xenopus |
title | Novel protein kinase C, nPKC, inhibition of murine bumetanide-sensitive Na+,K+,2Cl- cotransporter BSC1 in Xenopus oocyte |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A30%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20protein%20kinase%20C,%20nPKC,%20inhibition%20of%20murine%20bumetanide-sensitive%20Na+,K+,2Cl-%20cotransporter%20BSC1%20in%20Xenopus%20oocyte&rft.jtitle=Pfl%C3%BCgers%20Archiv&rft.au=Baekgaard,%20A&rft.date=1998-07-01&rft.volume=436&rft.issue=2&rft.spage=189&rft.epage=198&rft.pages=189-198&rft.issn=0031-6768&rft.eissn=1432-2013&rft_id=info:doi/10.1007/s004240050622&rft_dat=%3Cproquest_cross%3E2386652191%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=874022783&rft_id=info:pmid/9594018&rfr_iscdi=true |